A cohort study specifically examined the effects of metformin, insulin, and sulfonylureas on the risk of developing GC and found that the latter two drugs actually increased the risk of GC by elevating the levels of IGF-1, which promotes cancer cell survival [264]. This evidence concerns the gene IGF1 and cancer.